Newsroom archive

29 . 02 .2024
Press release
Galderma announces record 2023 net sales of over 4 B USD and significant core EBITDA margin expansion
  • Global release
AAD Presentations
28 . 02 .2024
News story
AAD 2024: scientific presentations supported by Galderma
AAD 2024
28 . 02 .2024
Press release
Galderma to showcase latest updates from its broad, innovative and leading dermatology portfolio at the 2024 American Academy of Dermatology annual meeting
  • Global release
14 . 02 .2024
Press release
Galderma announces regulatory filing acceptance for nemolizumab in prurigo nodularis and atopic dermatitis in the U.S. and EU
  • Global release
12 . 02 .2024
Making an impact
08 . 02 .2024
Press release
Galderma takes the ‘Face of Cetaphil®’ to the runway at New York City fashion week
  • Global release
07 . 02 .2024
Press release
Galderma launches ‘NEXT’, a ground-breaking trend report that unveils the future of aesthetics
  • Global release
02 . 02 .2024
Press release
Galderma celebrates 25 years of excellence in biostimulation with Sculptra® at the 2024 IMCAS
  • Global release
29 . 01 .2024
News story
The remarkable journey of Restylane, from the lab to the patient
IMCAS 2024 Galderma
25 . 01 .2024
News story
IMCAS 2024: Galderma’s scientific presentations